Literature DB >> 33470344

High glucose induces pyroptosis of retinal microglia through NLPR3 inflammasome signaling.

Libin Huang1, Junmei You1, Yao Yao1, Maosong Xie1.   

Abstract

PURPOSE: Diabetic retinopathy is currently considered a chronic inflammatory disease involving NOD-like receptor family pyrin domain containing 3 inflammasome activation and retinal microglial pyroptosis. In this study, we aimed to investigate whether NOD-like receptor family pyrin domain containing 3 inflammasome signaling induces pyroptotic death of retinal microglia under high-glucose conditions.
METHODS: Retinal microglia were stimulated by high glucose levels for 24 h. Cell viability, lactate dehydrogenase release, and caspase-1 activity were detected in vitro. The expression of pro-inflammatory cytokine (interleukin-1β, activated microglia marker ionized calcium-binding adapter molecule-1), NOD-like receptor family pyrin domain containing 3, cleaved caspase-1, and cleaved gasdermin D were examined. Subsequently, retinal microglia were pretreated with the inhibitors of NOD-like receptor family pyrin domain containing 3 inflammasome signaling prior to stimulation with high glucose, and their molecular and functional changes were evaluated.
RESULTS: High-glucose (25, 50, or 100 mM) stimulation decreased cell viability, but enhanced lactate dehydrogenase release and caspase-1 activity in a dose-dependent manner. Moreover, high glucose upregulated the protein expression of interleukin-1β, ionized calcium-binding adapter molecule-1, NOD-like receptor family pyrin domain containing 3, cleaved caspase-1, and cleaved gasdermin D. However, pretreatment with the inhibitors of NOD-like receptor family pyrin domain containing 3 inflammasome signaling inhibited high glucose (25 mM)-induced cytotoxicity, NOD-like receptor family pyrin domain containing 3 inflammasome activation, and pyroptosis of retinal microglia.
CONCLUSIONS: NOD-like receptor family pyrin domain containing 3 inflammasome signaling may modulate retinal microglia-related inflammation and pyroptosis under high-glucose conditions.

Entities:  

Year:  2021        PMID: 33470344     DOI: 10.5935/0004-2749.20210010

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  6 in total

Review 1.  Hypothalamic inflammation in metabolic disorders and aging.

Authors:  Anup Bhusal; Md Habibur Rahman; Kyoungho Suk
Journal:  Cell Mol Life Sci       Date:  2021-12-15       Impact factor: 9.261

Review 2.  Targeting Novel Regulated Cell Death: Pyroptosis, Necroptosis, and Ferroptosis in Diabetic Retinopathy.

Authors:  Sheng Gao; Yun Zhang; Meixia Zhang
Journal:  Front Cell Dev Biol       Date:  2022-06-23

Review 3.  Spotlight on pyroptosis: role in pathogenesis and therapeutic potential of ocular diseases.

Authors:  Meini Chen; Rong Rong; Xiaobo Xia
Journal:  J Neuroinflammation       Date:  2022-07-14       Impact factor: 9.587

Review 4.  Pyroptosis in the Retinal Neurovascular Unit: New Insights Into Diabetic Retinopathy.

Authors:  Chunren Meng; Chufeng Gu; Shuai He; Tong Su; Thashi Lhamo; Deji Draga; Qinghua Qiu
Journal:  Front Immunol       Date:  2021-10-19       Impact factor: 7.561

5.  Down-regulation of LCN2 attenuates retinal vascular dysfunction and caspase-1-mediated pyroptosis in diabetes mellitus.

Authors:  Xingjie Su; Pingping Zhou; Yanxiu Qi
Journal:  Ann Transl Med       Date:  2022-06

Review 6.  Targeting Pyroptosis: New Insights into the Treatment of Diabetic Microvascular Complications.

Authors:  Junling Gu; Kang Geng; Man Guo; Wei Huang; Tingting Zhao; Xuling Li; You-Hua Xu; Yong Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-27       Impact factor: 2.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.